Sanofi on Friday announced it has reached a licensing agreement with Novavax to sell a stand-alone COVID-19 vaccine and ...

Saroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist.

Mitigating inflammatory cytokine release that is typically seen with standard CD19 CAR T signaling may lead to reduced ...

All eight patients from GEMINI-1 who responded to a single intravenous (IV) imsidolimab dose and were subsequently re-randomized to monthly ...

Topline GSBR-1290 Phase 2a 12-week obesity data on track for June 2024Phase 2b study in obesity expected to begin as planned in the fourth ...

Sanofi on Friday announced it has reached a 'co-exclusive' licensing agreement with Novavax to sell a stand-alone COVID-19 ...

Drs Jacob Sands and Benjamin P. Levy discuss antibody-drug conjugates in lung cancer treatment, including differences in ...

Q1 2024 Earnings Call Transcript May 8, 2024 Revolution Medicines, Inc. isn’t one of the 30 most popular stocks among hedge ...

Merck (MRK) stock slipped as a Phase 3 trial for Keytruda with chemotherapy as a first-line option fails in endometrial ...

An autologous and personalized regulatory T cell therapy is safe in patients with type 1 diabetes, but does not help preserve ...

Tolerability and safety have been dramatically improved compared to existing products, and it is expected to be effective in ...

Since the level of experience with treating Rett patients outside of centers of excellence is lower, we're delivering ...